These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 433742)

  • 21. Antiarrhythmic drug effect assessed from ventricular arrhythmia reduction in the ambulatory electrocardiogram and treadmill test: comparison of propranolol, procainamide and quinidine.
    Winkle RA; Gradman AH; Fitzgerald JW
    Am J Cardiol; 1978 Sep; 42(3):473-80. PubMed ID: 685858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indocyanine green clearance following single and chronic cimetidine doses.
    MacKichan JJ; Schaal SF; Stine RA; Boudoulas H
    Res Commun Chem Pathol Pharmacol; 1984 May; 44(2):323-6. PubMed ID: 6739959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Steady-state plasma concentrations of quinidine and propranolol.
    Mayersohn M; Perrier D; Fenster P; Marcus FI
    Am Heart J; 1979 May; 97(5):678-9. PubMed ID: 433743
    [No Abstract]   [Full Text] [Related]  

  • 24. [Combined treatment with quinidine-propranolol for arrhythmia].
    Hardell LI; Warmenius S
    Lakartidningen; 1969 Sep; 66(38):3827-32. PubMed ID: 5384292
    [No Abstract]   [Full Text] [Related]  

  • 25. Electrophysiology and pharmacology of cardiac arrhythmias. IX. Cardiac electrophysiologic effects of beta adrenergic receptor stimulation and blockade. Part B.
    Wit AL; Hoffman BF; Rosen MR
    Am Heart J; 1975 Nov; 90(5):665-75. PubMed ID: 242208
    [No Abstract]   [Full Text] [Related]  

  • 26. Apparent quinidine-induced digoxin toxicity after withdrawal of pentobarbital: a case of sequential drug interactions.
    Chapron DJ; Mumford D; Pitegoff GI
    Arch Intern Med; 1979 Mar; 139(3):363-5. PubMed ID: 426582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Propranolol metabolism by Cunninghamella bainieri.
    Foster BC; Buttar HS; Qureshi SA; McGilveray IJ
    Xenobiotica; 1989 May; 19(5):539-46. PubMed ID: 2750210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perioperative variability of binding of lidocaine, quinidine, and propranolol after cardiac operations.
    Davies RF; Dubé LM; Mousseau N; McGilveray I; Beanlands DS
    J Thorac Cardiovasc Surg; 1988 Oct; 96(4):634-41. PubMed ID: 3172810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conversion of chronic atrial fibrillation to sinus rhythm with combined propranolol and quinidine treatment.
    Stern S
    Am Heart J; 1967 Aug; 74(2):170-2. PubMed ID: 4952730
    [No Abstract]   [Full Text] [Related]  

  • 30. Mechanism for reduced drug clearance in patients with cirrhosis.
    Pessayre D; Lebrec D; Descatoire V; Peignoux M; Benhamou JP
    Gastroenterology; 1978 Mar; 74(3):566-71. PubMed ID: 631487
    [No Abstract]   [Full Text] [Related]  

  • 31. Haemodynamic changes following separate and combined administration of beta-blocking drugs and quinidine.
    Stern S
    Eur J Clin Invest; 1971 Sep; 1(6):432-6. PubMed ID: 5121734
    [No Abstract]   [Full Text] [Related]  

  • 32. Series on pharmacology in practice. 2. Antiarrhythmic drug therapy.
    Federman J; Vlietstra RE
    Mayo Clin Proc; 1979 Aug; 54(8):531-42. PubMed ID: 459565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quinidine in perspective: "The rise and fall of quinidine".
    Selzer A
    Heart Lung; 1982; 11(1):20-3. PubMed ID: 6915920
    [No Abstract]   [Full Text] [Related]  

  • 34. Disposition kinetics of oral quinidine when administered concurrently with propranolol.
    Kates RE; Blanford MF
    J Clin Pharmacol; 1979 Jul; 19(7):378-83. PubMed ID: 479382
    [No Abstract]   [Full Text] [Related]  

  • 35. Interaction of antacids with antiarrhythmics. V. Effect of aluminium hydroxide and magnesium oxide on the bioavailability of quinidine, procainamide and propranolol in dogs.
    Remon JP; Belpaire F; Van Severen R; Braeckman P
    Arzneimittelforschung; 1983; 33(1):117-20. PubMed ID: 6681962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interactions between drugs used in cardiology].
    Halawa B; Mazurek W
    Wiad Lek; 1980 Apr; 33(7):533-8. PubMed ID: 6994358
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical pharmacokinetics of quinidine.
    Ochs HR; Greenblatt DJ; Woo E
    Clin Pharmacokinet; 1980; 5(2):150-68. PubMed ID: 6988137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Quinidine-propranolol combination and ventricular tachycardia induced by ouabain].
    Bertin MC; Giudicelli JF; Boissier JR
    C R Seances Soc Biol Fil; 1973; 167(2):228-32. PubMed ID: 4802931
    [No Abstract]   [Full Text] [Related]  

  • 39. [Value of the quinidine propranolol association in the treatment of atrial fibrillation].
    Duchene-Marullaz P; Pignide L; Chollet P
    Presse Med (1893); 1971 Apr; 79(18):814. PubMed ID: 5089783
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparison of the experimental anti-arrhythmic properties of acebutolol (M and B 17,803), propranolol and practolol.
    Basil B; Jordan R; Loveless AH; Maxwell DR
    Br J Pharmacol; 1974 Mar; 50(3):323-33. PubMed ID: 4850183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.